Pila Pharma AB (publ) (STO:PILA)

Playa Hotels & Resorts Statistics

Total Valuation

Pila Pharma AB has a market cap or net worth of SEK 122.26 million. The enterprise value is 117.36 million.

Market Cap	122.26M
Enterprise Value	117.36M

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Pila Pharma AB has 42.08 million shares outstanding. The number of shares has increased by 20.66% in one year.

Current Share Class	42.08M
Shares Outstanding	42.08M
Shares Change (YoY)	+20.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.81%
Owned by Institutions (%)	10.11%
Float	26.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	154.78
PB Ratio	23.24
P/TBV Ratio	29.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.44
EV / Sales	148.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.21

Current Ratio	5.21
Quick Ratio	5.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,631.13

Financial Efficiency

Return on equity (ROE) is -188.57% and return on invested capital (ROIC) is -85.02%.

Return on Equity (ROE)	-188.57%
Return on Assets (ROA)	-69.05%
Return on Invested Capital (ROIC)	-85.02%
Return on Capital Employed (ROCE)	-154.13%
Revenue Per Employee	789,889
Profits Per Employee	-11.24M
Employee Count	1
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.25% in the last 52 weeks. The beta is 0.58, so Pila Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-56.25%
50-Day Moving Average	3.21
200-Day Moving Average	3.73
Relative Strength Index (RSI)	41.67
Average Volume (20 Days)	92,416

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pila Pharma AB had revenue of SEK 789,889 and -11.24 million in losses. Loss per share was -0.44.

Revenue	789,889
Gross Profit	789,889
Operating Income	-8.11M
Pretax Income	-11.24M
Net Income	-11.24M
EBITDA	-7.03M
EBIT	-8.11M
Loss Per Share	-0.44

Balance Sheet

The company has 4.89 million in cash and n/a in debt, giving a net cash position of 4.89 million or 0.12 per share.

Cash & Cash Equivalents	4.89M
Total Debt	n/a
Net Cash	4.89M
Net Cash Per Share	0.12
Equity (Book Value)	5.26M
Book Value Per Share	0.19
Working Capital	4.05M

Cash Flow

Operating Cash Flow	-7.82M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-1,026.62%
Pretax Margin	-1,423.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pila Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.66%
Shareholder Yield	n/a
Earnings Yield	-9.19%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pila Pharma AB has an Altman Z-Score of 34.06 and a Piotroski F-Score of 2.

Altman Z-Score	34.06
Piotroski F-Score	2